Paper Review Records
All Paper Review Records
14 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
66
days
Acute management of adult MOG antibody–associated disease: therapeutic choices and clinical outcomes
Authors
Edgar Carnero Contentti; Eoin P. Flanagan; Ethel CiampiShow moreShow less
Affiliations
1. Hospital Alemán; 2. INECO Neurociencias Oroño; 3. Mayo Clinic College of Medicine; 4. Pontificia Universidad Católica de Chile; 5. Red de Salud UC CHRISTUS; 6. Hospital Dr Sotero del RioShow moreShow less
48
days
Beyond triptans in menstrual migraine: the emerging role of CGRP-targeted therapies
Authors
Lanfranco Pellesi; Damiana Scuteri; Andrea Burgalassi; Alberto Chiarugi; Paolo MartellettiShow moreShow less
Affiliations
1. University of Southern Denmark; 2. University “Magna Graecia” of Catanzaro; 3. Careggi University Hospital; 4. Unitelma Sapienza University of RomeShow moreShow less
95
days
Emerging small molecules for ulcerative colitis: clinical advancements and trial insights
Authors
Cristina Lanzotti; Fabrizio Fanizzi; Ferdinando D’Amico; Alessandra Zilli; Federica Furfaro; Mariangela Allocca; Virginia Solitano; Clelia Cicerone; Sara Massironi; Tommaso Lorenzo Parigi; Laurent Peyrin-Biroulet; Silvio DaneseShow moreShow less
Affiliations
1. IRCCS San Raffaele Hospital; 2. Vita-Salute San Raffaele University; 3. Istituti Ospedalieri Bergamaschi; 4. INFINY Institute, CHRU NancyShow moreShow less
135
days
Emerging claudin-18.2 antagonists in the treatment of biliary tract cancer
Authors
Daniel Neureiter; Dino Bekric; Christian Mayr; Tobias Kiesslich; Matthias OckerShow moreShow less
Affiliations
1. Paracelsus Medical University/University Hospital Salzburg (SALK); 2. Cancer Cluster Salzburg; 3. Paracelsus Medical University; 4. University Clinics Salzburg, Paracelsus Medical University; 5. Campus Charité Mitte, Charité University Medicine Berlin; 6. EO Translational Insights Consulting GmbH; 7. Tacalyx GmbHShow moreShow less
420
days
Emerging pharmacotherapies in Gaucher disease
Authors
Gregory M. PastoresShow moreShow less
Affiliations
1. University College DublinShow moreShow less
74
days
Phase II and III trials in systemic sclerosis: from recent FDA approvals to emerging applications of cellular therapies
Authors
Alain Lescoat; Eisha Naveed; Dinesh KhannaShow moreShow less
Affiliations
1. University of Rennes CHU Rennes, Inserm, EHESP; 2. University of Michigan Scleroderma ProgramShow moreShow less
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
